Skip to Content
 

News: Breast Cancer

Study backs genetic testing for all metastatic breast cancer patients

Friday, September 6th, 2019

Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

A “rheostat” for cancer signals

Friday, August 30th, 2019

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Saturday, June 29th, 2019

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk, according to a study published in Journal of the National Cancer Institute.

Vanderbilt surgeons lead nation in study to restore sensation in breast tissue

Friday, June 7th, 2019

Vanderbilt University Medical Center is the nation’s leading recruitment site for a new study examining the effectiveness of donor nerve grafts to restore sensation to breast tissue following mastectomy and reconstruction.

Technology better than tape measure for identifying lymphedema risk

Friday, May 17th, 2019

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.

Like racecars and geese, cancer cells draft their way to new tumor sites

Friday, April 5th, 2019

Finding gives boost to fighting cancer through cell metabolism

Study finds patient messages help predict medication adherence

Monday, February 4th, 2019

Breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others, enabling doctors to better predict which patients are at risk of stopping their treatment early.

Research team documents potential new treatment path for breast cancer

Friday, January 18th, 2019

Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change.

Next Page »